Medical Group
RSS Feeds Peertechz

Global Journal of Allergy  Open Access


    Iodixanol Nasal Solution Reduces Allergic Rhinoconjunctivitis Signs and Symptoms in Allergen BioCube®: Randomized Clinical Trial e-certificate

    DOI Logo 10.17352/2455-8141.000021

    Published On: October 05, 2018 | Pages: 001 - 008

    Author(s): Gomes PJ*, Abelson MB, Stein L, Viirre E, Villafranca JE and Lasser EC
    Importance: Allergic rhinitis affects about 20% of the population worldwide. Available pharmacological treatments are helpful but not ideal in providing relief; safer and more effective treatments are needed. Objective: To evaluate the efficacy and safety of Nasapaque nasal solution vs placebo for relief or prophylactic treatment of seasonal allergic rhinitis. ...
    Abstract View Full Article View Get Citation



    Find more...

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on Allergy